4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001209191-21-049118
Director sold 15,593 shares at an average $45.01 ($701,774)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Prokupets Elena Director | 2021-07-29 | Sale | −11,336 | $45.00 | $510,168 | 107,238 | I: show line 1 in the form |
| Prokupets Elena Director | 2021-08-02 | Sale | −4,257 | $45.01 | $191,606 | 102,981 | I: show line 2 in the form |
| Open-market sales · 15,593 sh · avg $45.01 · $701,774 | |||||||
Loading xslF345X03/doc4.xml…